Urban Scheuring
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Renal cell carcinoma treatment 6
- Lung Cancer Treatments and Mutations 6
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Dieter Hoelzer (12 shared papers)Cezary Szczylik (4 shared papers)Michael Staehler (3 shared papers)Sylvie Négrier (3 shared papers)Bernard Escudier (3 shared papers)Thomas E. Hutson (3 shared papers)Ronald M. Bukowski (3 shared papers)Frédéric Rolland (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Blood (4 papers)Annals of Oncology (4 papers)Leukemia (3 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Urban Scheuring
38 papers receiving 1.9k citations
Urban Scheuring's Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 671
- Public Health, Environmental and Occupational Health 661
- Cancer Research 310
- Pulmonary and Respiratory Medicine 575
- Oncology 476
Countries citing papers authored by Urban Scheuring
This map shows the geographic impact of Urban Scheuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urban Scheuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urban Scheuring more than expected).
Fields of papers citing papers by Urban Scheuring
This network shows the impact of papers produced by Urban Scheuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urban Scheuring. The network helps show where Urban Scheuring may publish in the future.
Co-authors
The 25 scholars most cited alongside Urban Scheuring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 390 | |
| 2 | Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2009 | 379 |
| 3 | 2005 | 151 | |
| 4 | 2020 | 121 | |
| 5 | 2007 | 104 | |
| 6 | 2020 | 88 | |
| 7 | Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. | 2003 | 77 |
| 8 | 2002 | 58 | |
| 9 | 2002 | 52 | |
| 10 | 2002 | 47 | |
| 11 | 2006 | 46 | |
| 12 | 2019 | 43 | |
| 13 | 2003 | 39 | |
| 14 | 2003 | 29 | |
| 15 | 1998 | 29 | |
| 16 | 2003 | 27 | |
| 17 | 2021 | 20 | |
| 18 | 2001 | 19 | |
| 19 | 2003 | 18 | |
| 20 | 2003 | 16 |
About Urban Scheuring
Urban Scheuring is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Public Health, Environmental and Occupational Health and Virology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers), HIV Research and Treatment (6 papers), Eosinophilic Disorders and Syndromes (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (671 citations), Public Health, Environmental and Occupational Health (661 citations), Cancer Research (310 citations), Pulmonary and Respiratory Medicine (575 citations) and Oncology (476 citations). Urban Scheuring has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Dieter Hoelzer, Cezary Szczylik, Michael Staehler, Sylvie Négrier, Bernard Escudier, Thomas E. Hutson, Ronald M. Bukowski, Frédéric Rolland, Tomasz Demkow and Oliver G. Ottmann. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Leukemia and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.